[1]
“Migraine: prevalence, body mass index, blood group and comorbidities; a prospective observational study”, Int. J. of Res. in Pharmacology &Pharmacotherapeutics , vol. 6, no. 3, pp. 255–261, Apr. 2021, doi: 10.61096/ijrpp.v6.iss3.2017.255-261.